Please enable JavaScript to continue using this application.

Compare $CGEM vs $SVRA | Chartloom

Compare

$CGEM vs $SVRA

Cullinan Therapeutics Inc · Savara Inc

CGEM

Cullinan Therapeutics Inc

SVRA

Savara Inc

Compare $CGEM vs $SVRA

Comparing Cullinan Therapeutics Inc and Savara Inc

CGEMCullinan Therapeutics Inc

SVRASavara Inc

CGEMCullinan Therapeutics Inc

Market cap

$954M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.5%

52W performance

140.8%

FCF yield

-16.7%

SVRASavara Inc

Market cap

$1.01B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

22.71x

Rev growth (TTM)

—

YTD performance

-12.8%

52W performance

41.8%

FCF yield

-11.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CGEM

SVRA

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

SVRA

Savara Inc

Market Cap

CGEM$954M

SVRA$1.01B

Enterprise Value

CGEM$876M

SVRA$997M

Price

CGEM$15.53

SVRA$4.92

P/E Ratio

CGEMN/A

SVRAN/A

P/S Ratio

CGEM0.00x

SVRA3,801.01x

EV/Sales

CGEM0.00x

SVRA3,756.05x

EV/EBITDA

CGEM8.02x

SVRA0.00x

P/B Ratio

CGEM3.10x

SVRA6.88x

P/FCF Ratio

CGEMN/A

SVRAN/A

EV/FCF

CGEM-5.50x

SVRA-9.01x

PEG Ratio

CGEMN/A

SVRAN/A

Forward P/E (NTM)

CGEMN/A

SVRAN/A

Forward P/S (NTM)

CGEMN/A

SVRA22.71x

Revenue (TTM)

CGEM$0

SVRA$0

Revenue Growth (YoY)

CGEMN/A

SVRAN/A

Forward Rev Growth

CGEM244.6%

SVRA3388.8%

Gross Margin (TTM)

CGEM0.0%

SVRA0.0%

Operating Margin (TTM)

CGEM0.0%

SVRA0.0%

EBITDA Margin (TTM)

CGEM0.0%

SVRA0.0%

Net Margin (TTM)

CGEM0.0%

SVRA0.0%

FCF Margin (TTM)

CGEMN/A

SVRAN/A

Net Income (TTM)

CGEM$-205M

SVRA$-139M

FCF (TTM)

CGEM$-159M

SVRA$-111M

EPS (TTM)

CGEM-$3.33

SVRA-$0.55

ROE (TTM)

CGEM-5289.0%

SVRA-9028.0%

ROA (TTM)

CGEM-4818.0%

SVRA-6895.0%

ROIC (TTM)

CGEM-5289.0%

SVRA-7560.0%

Cash

CGEM$79M

SVRA$42M

Debt

CGEM$0

SVRA$30M

Net Cash/Debt

CGEM$79M

SVRA$12M

Current Ratio (TTM)

CGEM8.42x

SVRA10.13x

Quick Ratio (TTM)

CGEM8.23x

SVRA10.00x

Debt/Equity (TTM)

CGEM0.00x

SVRA0.21x

Debt/Assets (TTM)

CGEM0.0%

SVRA0.0%

Interest Coverage (TTM)

CGEMN/A

SVRAN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

SVRA0.00x

Beta

CGEM-0.03

SVRA0.28

52W Performance

CGEM140.8%

SVRA41.8%

YTD Performance

CGEM53.5%

SVRA-12.8%

% from 52W High

CGEM-33.0%

SVRA-29.8%

% from 52W Low

CGEM138.9%

SVRA46.9%

Asset Turnover (TTM)

CGEM0.00x

SVRA0.00x

FCF Yield (TTM)

CGEM-16.7%

SVRA-11.0%

Earnings Yield (TTM)

CGEM-21.4%

SVRA-13.8%

Dividend Yield (TTM)

CGEMN/A

SVRAN/A

Rule of 40

CGEM0.0

SVRA0.0

EV/GP/RG

CGEMN/A

SVRAN/A

Ticker research

View CGEM research View SVRA research

Metric	CGEM Cullinan Therapeutics Inc	SVRA Savara Inc
Market & Valuation
Market Cap	$954M	$1.01B
Enterprise Value	$876M	$997M
Price	$15.53	$4.92
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3,801.01x
EV/Sales	0.00x	3,756.05x
EV/EBITDA	8.02x	0.00x
P/B Ratio	3.10x	6.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-9.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	22.71x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	244.6%	3388.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-205M	$-139M
FCF (TTM)	$-159M	$-111M
EPS (TTM)	-$3.33	-$0.55
ROE (TTM)	-5289.0%	-9028.0%
ROA (TTM)	-4818.0%	-6895.0%
ROIC (TTM)	-5289.0%	-7560.0%
Financial Health
Cash	$79M	$42M
Debt	$0	$30M
Net Cash/Debt	$79M	$12M
Current Ratio (TTM)	8.42x	10.13x
Quick Ratio (TTM)	8.23x	10.00x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	0.28
52W Performance	140.8%	41.8%
YTD Performance	53.5%	-12.8%
% from 52W High	-33.0%	-29.8%
% from 52W Low	138.9%	46.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.7%	-11.0%
Earnings Yield (TTM)	-21.4%	-13.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGEM research	View SVRA research

Valuation

P/S Ratio

CGEM

0.00x

SVRA

3,801.01x

EV/FCF

SVRA

-9.01x

CGEM

-5.50x

Growth & revenue

Forward Revenue Growth

SVRA

3388.8%

CGEM

244.6%

Profitability & performance

Gross Margin

CGEM

0.0%

SVRA

0.0%

ROE

CGEM

-5289.0%

SVRA

-9028.0%

FCF Yield %

SVRA

-11.0%

CGEM

-16.7%

52-Week Performance

CGEM

140.8%

SVRA

41.8%

Detailed metrics comparison

CGEM

Cullinan Therapeutics Inc

SVRA

Savara Inc

Market Cap

CGEM$954M

SVRA$1.01B

Enterprise Value

CGEM$876M

SVRA$997M

Price

CGEM$15.53

SVRA$4.92

P/E Ratio

CGEMN/A

SVRAN/A

P/S Ratio

CGEM0.00x

SVRA3,801.01x

EV/Sales

CGEM0.00x

SVRA3,756.05x

EV/EBITDA

CGEM8.02x

SVRA0.00x

P/B Ratio

CGEM3.10x

SVRA6.88x

P/FCF Ratio

CGEMN/A

SVRAN/A

EV/FCF

CGEM-5.50x

SVRA-9.01x

PEG Ratio

CGEMN/A

SVRAN/A

Forward P/E (NTM)

CGEMN/A

SVRAN/A

Forward P/S (NTM)

CGEMN/A

SVRA22.71x

Revenue (TTM)

CGEM$0

SVRA$0

Revenue Growth (YoY)

CGEMN/A

SVRAN/A

Forward Rev Growth

CGEM244.6%

SVRA3388.8%

Gross Margin (TTM)

CGEM0.0%

SVRA0.0%

Operating Margin (TTM)

CGEM0.0%

SVRA0.0%

EBITDA Margin (TTM)

CGEM0.0%

SVRA0.0%

Net Margin (TTM)

CGEM0.0%

SVRA0.0%

FCF Margin (TTM)

CGEMN/A

SVRAN/A

Net Income (TTM)

CGEM$-205M

SVRA$-139M

FCF (TTM)

CGEM$-159M

SVRA$-111M

EPS (TTM)

CGEM-$3.33

SVRA-$0.55

ROE (TTM)

CGEM-5289.0%

SVRA-9028.0%

ROA (TTM)

CGEM-4818.0%

SVRA-6895.0%

ROIC (TTM)

CGEM-5289.0%

SVRA-7560.0%

Cash

CGEM$79M

SVRA$42M

Debt

CGEM$0

SVRA$30M

Net Cash/Debt

CGEM$79M

SVRA$12M

Current Ratio (TTM)

CGEM8.42x

SVRA10.13x

Quick Ratio (TTM)

CGEM8.23x

SVRA10.00x

Debt/Equity (TTM)

CGEM0.00x

SVRA0.21x

Debt/Assets (TTM)

CGEM0.0%

SVRA0.0%

Interest Coverage (TTM)

CGEMN/A

SVRAN/A

Net Debt/EBITDA (TTM)

CGEM0.00x

SVRA0.00x

Beta

CGEM-0.03

SVRA0.28

52W Performance

CGEM140.8%

SVRA41.8%

YTD Performance

CGEM53.5%

SVRA-12.8%

% from 52W High

CGEM-33.0%

SVRA-29.8%

% from 52W Low

CGEM138.9%

SVRA46.9%

Asset Turnover (TTM)

CGEM0.00x

SVRA0.00x

FCF Yield (TTM)

CGEM-16.7%

SVRA-11.0%

Earnings Yield (TTM)

CGEM-21.4%

SVRA-13.8%

Dividend Yield (TTM)

CGEMN/A

SVRAN/A

Rule of 40

CGEM0.0

SVRA0.0

EV/GP/RG

CGEMN/A

SVRAN/A

Ticker research

View CGEM research View SVRA research

Metric	CGEM Cullinan Therapeutics Inc	SVRA Savara Inc
Market & Valuation
Market Cap	$954M	$1.01B
Enterprise Value	$876M	$997M
Price	$15.53	$4.92
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3,801.01x
EV/Sales	0.00x	3,756.05x
EV/EBITDA	8.02x	0.00x
P/B Ratio	3.10x	6.88x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.50x	-9.01x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	22.71x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	244.6%	3388.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-205M	$-139M
FCF (TTM)	$-159M	$-111M
EPS (TTM)	-$3.33	-$0.55
ROE (TTM)	-5289.0%	-9028.0%
ROA (TTM)	-4818.0%	-6895.0%
ROIC (TTM)	-5289.0%	-7560.0%
Financial Health
Cash	$79M	$42M
Debt	$0	$30M
Net Cash/Debt	$79M	$12M
Current Ratio (TTM)	8.42x	10.13x
Quick Ratio (TTM)	8.23x	10.00x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.03	0.28
52W Performance	140.8%	41.8%
YTD Performance	53.5%	-12.8%
% from 52W High	-33.0%	-29.8%
% from 52W Low	138.9%	46.9%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-16.7%	-11.0%
Earnings Yield (TTM)	-21.4%	-13.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CGEM research	View SVRA research